NM_001352514.2:c.*2622G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001352514.2(HLCS):​c.*2622G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.43 in 152,324 control chromosomes in the GnomAD database, including 14,310 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.43 ( 14295 hom., cov: 33)
Exomes 𝑓: 0.45 ( 15 hom. )

Consequence

HLCS
NM_001352514.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.449

Publications

6 publications found
Variant links:
Genes affected
HLCS (HGNC:4976): (holocarboxylase synthetase) This gene encodes an enzyme that catalyzes the binding of biotin to carboxylases and histones. The protein plays an important role in gluconeogenesis, fatty acid synthesis and branched chain amino acid catabolism. Defects in this gene are the cause of holocarboxylase synthetase deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Jun 2011]
HLCS Gene-Disease associations (from GenCC):
  • holocarboxylase synthetase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 21-36751624-C-T is Benign according to our data. Variant chr21-36751624-C-T is described in ClinVar as Benign. ClinVar VariationId is 339920.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.578 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001352514.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLCS
NM_001352514.2
MANE Select
c.*2622G>A
3_prime_UTR
Exon 11 of 11NP_001339443.1P50747-2
HLCS
NM_000411.8
c.*2622G>A
3_prime_UTR
Exon 12 of 12NP_000402.3
HLCS
NM_001242784.3
c.*2622G>A
3_prime_UTR
Exon 12 of 12NP_001229713.1P50747-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLCS
ENST00000674895.3
MANE Select
c.*2622G>A
3_prime_UTR
Exon 11 of 11ENSP00000502087.2P50747-2
HLCS
ENST00000336648.8
TSL:1
c.*2622G>A
3_prime_UTR
Exon 12 of 12ENSP00000338387.3P50747-1
HLCS
ENST00000399120.5
TSL:1
c.*2622G>A
3_prime_UTR
Exon 12 of 12ENSP00000382071.1P50747-1

Frequencies

GnomAD3 genomes
AF:
0.430
AC:
65430
AN:
152088
Hom.:
14275
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.373
Gnomad AMI
AF:
0.531
Gnomad AMR
AF:
0.409
Gnomad ASJ
AF:
0.490
Gnomad EAS
AF:
0.410
Gnomad SAS
AF:
0.597
Gnomad FIN
AF:
0.411
Gnomad MID
AF:
0.516
Gnomad NFE
AF:
0.457
Gnomad OTH
AF:
0.459
GnomAD4 exome
AF:
0.449
AC:
53
AN:
118
Hom.:
15
Cov.:
0
AF XY:
0.471
AC XY:
49
AN XY:
104
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
0.250
AC:
1
AN:
4
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
1
AN:
2
East Asian (EAS)
AF:
0.500
AC:
4
AN:
8
South Asian (SAS)
AF:
0.500
AC:
1
AN:
2
European-Finnish (FIN)
AF:
0.700
AC:
7
AN:
10
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.432
AC:
38
AN:
88
Other (OTH)
AF:
0.250
AC:
1
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.430
AC:
65468
AN:
152206
Hom.:
14295
Cov.:
33
AF XY:
0.430
AC XY:
32014
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.373
AC:
15503
AN:
41548
American (AMR)
AF:
0.408
AC:
6244
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.490
AC:
1703
AN:
3472
East Asian (EAS)
AF:
0.410
AC:
2117
AN:
5166
South Asian (SAS)
AF:
0.596
AC:
2876
AN:
4828
European-Finnish (FIN)
AF:
0.411
AC:
4351
AN:
10586
Middle Eastern (MID)
AF:
0.524
AC:
153
AN:
292
European-Non Finnish (NFE)
AF:
0.457
AC:
31070
AN:
68000
Other (OTH)
AF:
0.459
AC:
968
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1971
3942
5913
7884
9855
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
634
1268
1902
2536
3170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.434
Hom.:
10101
Bravo
AF:
0.426
Asia WGS
AF:
0.507
AC:
1760
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Holocarboxylase synthetase deficiency (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.2
DANN
Benign
0.52
PhyloP100
-0.45
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs14407; hg19: chr21-38123925; API